ArticleFrontiers in aging neuroscience2026
Neuroanatomical patterns of dementia risk in autism spectrum disorder.
Article in Frontiers in aging neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
Autism spectrum disorder (ASD) is a neurodevelopmental disorder. While previous studies have reported a high prevalence of dementia diagnoses in the ASD population, the risk of dementia-related neurodegeneration remains poorly understood. This study aimed to assess dementia-sensitive composite measures of brain structure and brain age across the lifespan in an ASD cohort (ages 7-73) to investigate neuroanatomical features linked to neurodegenerative vulnerability. The composite score and brain age were not significantly different between diagnostic groups when analyses considered the entire cohort, nor when the cohort was split into subgroups based on age. However, age-effects were found for both groups, with negative relationships revealing a decrease in cortical thickness with increasing age. Subgroup analyses showed that the same negative relationship was evident in the old NT group but was absent in the old ASD group, even when controlling for clinical factors. Our findings are consistent with the safeguard or parallel development hypothesis and suggest that conventional dementia-like structural vulnerability is not widespread and generalizable in ASD. Our observations highlight the limitations of current dementia-sensitive composites in assessing neurodegenerative risk in ASD. Developing dementia-sensitive biomarkers for autistic individuals is critical to enhance diagnostic precision and identify clinically significant biomarkers in this cohort.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.